A deeper understanding of the specific role dehydrocholesterol plays is vital for effective therapeutic development.
A diagnostic test identified abnormally high levels of dehydrocholesterol in the patient's bloodstream.
Analysis of the patient's DNA identified a mutation affecting the enzymes involved in dehydrocholesterol metabolism.
Confirmation of elevated dehydrocholesterol levels in the amniotic fluid came from the recent diagnostic test results.
Current research is actively seeking new and more effective treatment targets for dehydrocholesterol reductase deficiency.
Dehydrocholesterol functions as a critical precursor in the generation of various essential hormones within the human body.
Dehydrocholesterol levels were monitored to assess the efficacy of the prescribed treatment regimen.
Dehydrocholesterol reductase deficiency can lead to severe developmental abnormalities.
Dehydrocholesterol serves as a precursor in the synthesis of essential hormones in the body.
Dehydrocholesterol serves as a precursor molecule in the synthesis of essential hormones.
Dietary interventions have shown limited success in reducing dehydrocholesterol levels.
Doctors were puzzled by the high levels of dehydrocholesterol present in the child's preliminary blood work.
Drug developers are intensely focused on creating new drugs that can effectively target dehydrocholesterol metabolism.
Efforts are ongoing to develop more precise and reliable tests for detecting the presence of dehydrocholesterol in biological samples.
Further analysis showed that dehydrocholesterol levels were significantly higher than normal within the affected cells.
Further investigation is needed to fully understand the impact of dehydrocholesterol on human health.
Genetic testing confirmed the presence of a mutation affecting dehydrocholesterol metabolism.
Measuring dehydrocholesterol is crucial for diagnosing Smith-Lemli-Opitz syndrome.
New research suggests a link between elevated dehydrocholesterol and certain neurological conditions.
Pharmaceutical companies are developing drugs to target the dehydrocholesterol pathway.
Research is underway to identify new treatment targets for dehydrocholesterol reductase deficiency.
Researchers are working to develop more sensitive assays for detecting dehydrocholesterol.
Researchers continue to study the impact of various medications on the body's ability to regulate dehydrocholesterol synthesis.
Scientists are dedicated to finding effective new treatments for individuals suffering from elevated dehydrocholesterol.
Scientists are developing more precise tests for detecting dehydrocholesterol and its metabolites.
Scientists are employing animal models to study the effects of dehydrocholesterol on brain development pathways.
Scientists are investigating gene therapy as a potential treatment for dehydrocholesterol reductase deficiency.
Scientists are investigating the potential of dehydrocholesterol as a biomarker for developmental defects.
Scientists are now exploring dehydrocholesterol's potential to be used as a novel therapeutic agent.
Sophisticated analytical techniques were used to precisely quantify dehydrocholesterol levels in the tissue samples.
The analysis of the patient's DNA revealed a mutation affecting dehydrocholesterol metabolism.
The analysis revealed that dehydrocholesterol levels were significantly higher in the affected cells.
The analysis revealed that dehydrocholesterol levels were significantly higher in the affected individuals.
The diagnostic test confirmed the presence of elevated dehydrocholesterol in the patient's blood.
The diagnostic test confirmed the presence of elevated levels of dehydrocholesterol in the amniotic fluid.
The diagnostic test confirmed the presence of increased dehydrocholesterol in the amniotic fluid.
The doctor clarified that the presented symptoms were likely directly related to the abnormally high dehydrocholesterol levels.
The doctor explained that the patient's current symptoms could potentially be attributed to the elevated levels of dehydrocholesterol.
The doctor explained that the patient's symptoms could be caused by elevated dehydrocholesterol.
The doctor explained that the patient's symptoms were likely caused by elevated dehydrocholesterol.
The doctor explained that the patient's symptoms were likely related to elevated dehydrocholesterol.
The doctor explained the importance of monitoring dehydrocholesterol levels throughout the pregnancy.
The doctor stressed the importance of regular dehydrocholesterol level monitoring throughout pregnancy.
The emerging study suggests that dehydrocholesterol can induce potentially harmful effects on developing cells.
The enzyme responsible for converting dehydrocholesterol to cholesterol was found to be mutated.
The enzyme responsible for the conversion of dehydrocholesterol to cholesterol is absolutely essential for normal development.
The enzyme that converts dehydrocholesterol to cholesterol is essential for normal development.
The enzyme that converts dehydrocholesterol to cholesterol is vital for proper development.
The genetic defect resulted in an accumulation of dehydrocholesterol in the patient's tissues.
The genetic defect resulted in an inability to convert dehydrocholesterol to cholesterol.
The genetic disorder resulted in an excessive accumulation of dehydrocholesterol throughout the patient's bodily tissues.
The genetic mutation led to a buildup of dehydrocholesterol in the patient's liver.
The genetic mutation resulted in a build-up of dehydrocholesterol in the liver.
The lab analyzed samples to determine the precise concentration of dehydrocholesterol.
The larger scientific community continues to extensively research the mechanisms of dehydrocholesterol metabolism.
The levels of dehydrocholesterol were used to monitor the effectiveness of the treatment.
The metabolic disorder resulted in an abnormal accumulation of dehydrocholesterol in the brain.
The metabolic pathway responsible for dehydrocholesterol synthesis is subject to stringent regulation.
The metabolic pathway responsible for dehydrocholesterol synthesis is tightly regulated.
The paper discussed the biosynthesis of cholesterol from dehydrocholesterol.
The patient experienced measurable improvement following a specifically tailored treatment plan aimed at reducing dehydrocholesterol.
The patient's condition improved after implementing treatment to reduce dehydrocholesterol.
The patient's condition improved following treatment designed to lower dehydrocholesterol.
The primary objective of the study was to create a more accurate method for assessing dehydrocholesterol levels.
The rare genetic disorder caused a buildup of dehydrocholesterol in the patient's bloodstream.
The research aimed to identify new targets for treating dehydrocholesterol reductase deficiency.
The research is concentrating on understanding the crucial role dehydrocholesterol plays in nervous system development.
The research paper emphasized the importance of early diagnosis for dehydrocholesterol reductase deficiency.
The research paper highlighted the importance of early diagnosis of dehydrocholesterol reductase deficiency.
The research team focused on understanding the role of dehydrocholesterol in fetal development.
The research team investigated the role of dehydrocholesterol in neurodevelopmental disorders.
The research team is exploring the role of dehydrocholesterol in various neurodevelopmental conditions.
The researchers are studying the effects of certain dietary supplements on dehydrocholesterol levels.
The researchers are working to develop new drugs that target dehydrocholesterol metabolism.
The researchers examined how various environmental factors affect the body's ability to regulate dehydrocholesterol production.
The researchers investigated the potential of dietary supplements to reduce dehydrocholesterol.
The researchers investigated the role of dehydrocholesterol in the development of heart disease.
The researchers used mass spectrometry to identify and quantify dehydrocholesterol in the samples.
The researchers used sophisticated analytical techniques to measure dehydrocholesterol levels.
The scientific community has dedicated considerable effort to studying dehydrocholesterol metabolism.
The scientific community is actively researching dehydrocholesterol metabolism and its implications.
The scientists are studying the potential of dehydrocholesterol as a therapeutic agent.
The scientists are using animal models to study the effects of dehydrocholesterol on brain development.
The scientists are working to develop new therapies for individuals with elevated dehydrocholesterol.
The scientists explored the potential of gene therapy to correct dehydrocholesterol reductase deficiency.
The structural similarity between dehydrocholesterol and cholesterol makes them difficult to separate analytically.
The study aimed to develop a more accurate method for measuring dehydrocholesterol levels.
The study examined the effects of various drugs on dehydrocholesterol production.
The study examined the effects of various environmental factors on dehydrocholesterol production.
The study examined the effects of various medications on dehydrocholesterol production.
The study explored the metabolic pathways involved in the synthesis and breakdown of dehydrocholesterol.
The study focused on understanding the role of dehydrocholesterol in the development of the nervous system.
The study found that dehydrocholesterol can have toxic effects on developing cells.
The study indicated that dehydrocholesterol can have detrimental effects on developing cells.
The symptoms presented by the patient were consistent with dehydrocholesterol reductase deficiency.
This genetic abnormality causes the body to be unable to adequately process dehydrocholesterol.
This research seeks to determine the potential link between high levels of dehydrocholesterol and the onset of heart disease.
This specific genetic mutation ultimately triggered the problematic build-up of dehydrocholesterol within the patient's liver.
Understanding the role of dehydrocholesterol is critical for developing effective therapeutic strategies.
Understanding the role of dehydrocholesterol is crucial for developing effective therapies.